The most significant addition to the Java language since Sun Microsystems rewrote the collections API for Java 5 is the introduction of Java records. Java records address two significant pain points ...

To get started with Spring, the very first thing to do is spin up a basic, functioning Hello World Spring application that does one thing: display a simple greeting. In this Spring tutorial, we won't ...

BRUSSELS, April 14, 2026 (GLOBE NEWSWIRE) -- The Eclipse Foundation today announced the Open VSX Security Researcher Recognition Program, a new initiative designed to strengthen the security of the ...

MIT professor Joseph Weizenbaum developed Eliza in the mid-1960s. His views on artificial intelligence were often at odds with many of his fellow pioneers in the field. Illustration by Meilan Solly / ...

From chain link patterns, you can combine them as you like to create different products. You can flexibly change the material to suit the material you have. Change beads size or color to create your ...

Hello, and welcome to Vir Biotechnology's Third Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded. [Operator Instructions] I will now turn ...

Creating simple data classes in Java traditionally required substantial boilerplate code. Consider how we would represent Java’s mascots, Duke and Juggy: public class JavaMascot { private final String ...

Nearly a year after the University announced it was phasing out all 23 of the creative writing lecturers over the course of the next two years, the first set of lecturers have said their goodbyes to ...

The original version of this story appeared in Quanta Magazine. Imagine that someone gives you a list of five numbers: 1, 6, 21, 107, and—wait for it—47,176,870. Can you guess what comes next? If ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...